Does GEMFIBROZIL Cause Hypertransaminasaemia? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hypertransaminasaemia have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 1.5% of all adverse event reports for GEMFIBROZIL.
16
Reports of Hypertransaminasaemia with GEMFIBROZIL
1.5%
of all GEMFIBROZIL reports
0
Deaths
16
Hospitalizations
How Dangerous Is Hypertransaminasaemia From GEMFIBROZIL?
Of the 16 reports, 16 (100.0%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMFIBROZIL. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Rhabdomyolysis (63)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which GEMFIBROZIL Alternatives Have Lower Hypertransaminasaemia Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA